International Stem Cell Corporation (ISCO)
OTCMKTS · Delayed Price · Currency is USD
0.266004
+0.006004 (2.31%)
At close: Jul 31, 2026
International Stem Cell Market Cap
International Stem Cell has a market cap or net worth of $2.08 million as of July 31, 2026. Its market cap has increased by 77.27% in one year.
Market Cap
2.08M
Enterprise Value
8.97M
Revenue
9.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.27
ChartMarket Cap Chart
Since January 9, 2007, International Stem Cell's market cap has decreased from 89.40M to 2.08M, a decrease of -97.67%. That is a compound annual growth rate of -17.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 2.08M | 85.71% |
| Dec 31, 2025 | 1.12M | 72.20% |
| Dec 31, 2024 | 650.76K | 31.13% |
| Dec 29, 2023 | 496.27K | -65.56% |
| Dec 30, 2022 | 1.44M | -61.95% |
| Dec 31, 2021 | 3.79M | 35.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eastgate Biotech | 3.17M |
| Vaccinex | 3.16M |
| Enzolytics | 2.90M |
| CASI Pharmaceuticals | 2.85M |
| Bioxytran | 2.75M |
| Pacific Software | 2.56M |
| VitaSpring Biomedical | 2.30M |
| Bio-Path Holdings | 2.21M |